Publications

How well-written clinical study protocols get drugs to patients faster
In the world of drug development and approval, time is of the essence. But beginning the process with a poorly written protocol will only impede teams before a study has even begun. Julia Forjanic Klapproth, co-founder of Trilogy Writing & Consulting, describes how a well-written protocol will help patients receive their treatments sooner rather than later.

Strategic Benefits
Julia Forjanic Klapproth of Trilogy Writing and Consulting elucidates how strategic medical writingcan help communicate key messages across development programmes and make sure teamsstay focused on a common goal. I...

The Future Awaits Us
Off the back of the release of Trilogy Writing & Consulting’s second special edition magazine, EPC sits down with Barry Drees to expand on medical writing trends in the industry....

Quality-Driven Medical Writing
For years, the clinical drug development industry has been waging war against the surging drug development costs and tediously long processes. More efficient decision making during drug development would be...
Author: Stacey Smith
Journal: Pharma Tech Outlook, Clinical Trial Management Edition
Date: December 2019

Medical Writing in the Old World
Although there has been what amounts to medical writing here for a long time, it is a relatively new concept as a specialized profession.
Author: Barry Drees
Journal: The Write Stuff, The journal of EMWA
Date: Vol.8, No.3, 1999